Genistein Arrests Cell Cycle Progression at G2-M

Cancer Research

Volumn 53, Issue 6, 1993, Pages 1328-1331

  Matsukawa, Yoshizumi ^a,b   Matsumoto, Katsuhiko ^b   Sakai, Toshiyuki ^a   Yoshida, Mitsunori ^a   Aoike, Akira ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b Hyogo Institute for Oriental Medicine   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DAIDZEIN; DNA TOPOISOMERASE (ATP HYDROLYSING); FLAVONE; GENISTEIN; LUTEOLIN; PROTEIN TYROSINE KINASE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL CYCLE G2 PHASE; CELL CYCLE PHASE; CELL GROWTH; CONTROLLED STUDY; DOSE RESPONSE; ENZYME INHIBITION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; MITOSIS INDEX; PRIORITY JOURNAL; STOMACH CANCER;

G2 PHASE; GENISTEIN; GROWTH INHIBITORS; HUMAN; ISOFLAVONES; MITOSIS; MITOTIC INDEX; STOMACH NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0027479424     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Ambrose, A. M. Robbins, D. J. and Deeds, F. Comparative toxicities of quercetin and quercitrin. J. Am. Pharm. Assoc. 41: 119-122, 1951.
2. Bjeleldanes, L. F. and Chang, G. W. Mutagenic activity of quercetin and related compounds. Science (Washington DC), 197: 577-578, 1977.
3. Kim, J. H. Kim, S. H. Alfieri, A. A. and Young, C. W. Quercetin, an inhibitor of lactate transport and a hyperthermic sensitizer of HeLa cells. Cancer Res. 44: 102-106, 1984.
4. Macgregor, J. T. Genetic toxicology of dietary flavonoids. Prog. Clin. Biol. Res. 213: 33-43, 1986.
5. Soulinna, E.-M. Buchsbaum, R. N. and Racker, E. The effect of flavonoids on aerobic glycosis and growth of tumor cells. Cancer Res. 35: 1865-1872, 1975.
6. Yoshida, M. Sakai, T. Hosokawa, N. Marui, N. Matsumoto, K. Fujioka, A. Nishino, H. and Aoike, A. The effect of quercetin of cell cycle progression and growth of human gastric cancer cells. FEBS Lett. 260: 10-13, 1990.
7. Hosokawa, N. Hosokawa, Y. Sakai, T. Yoshida, M. Marui, N. Nishino, H. Kawai, K. and Aoike, A. Inhibitory effect of quercetin on the synthesis of a possibly cell-cycle-related 17 kDa protein, in human colon cancer cells. Int. J. Cancer, 45: 1119-1124, 1990.
8. Akagi, T. and Kimoto, T. Human cell line (HGC-27) derived from the metastatic lymph node of gastric cancer. Acta Med. Okayama, 30: 215-217, 1976.
9. Dean, P. N. A simplified method of DNA distribution analysis. Cell Tissue Kinet. 13: 299-308, 1980.
10. Akiyama, T. Ishida, J. Nakagawa, S. Ogawa, H. Watanabe, S. Itou, N. Shibata, M. and Fukami, Y. Genistein, a specific inhibitor of tyrosine-specific protein kinase. J. Biol. Chem. 262: 5592-5595, 1987.
11. End, D. W. Look, R. A. Shaffer, N. L. Balles, E. A. and Persico, F. J. Non-selective inhibition of mammalian protein kinases by flavonoids in vitro. Res. Commun. Chem. Pathol. Pharmacol. 56: 75-86, 1987.
12. Graziani, Y. Chayoth, R. Karny, N. Feldman, B. and Levy, J. Regulation of protein kinases activity by quercetin in Ehrlich ascites tumor cells. Biochem. Biophys. Acta, 714: 415-421, 1981.
13. Gautier, J. Matsukawa, T. Nurse, P. and Maller, J. Dephosphorylation and activation of Xenopus p34cdc2 protein kinase during the cell cycle. Nature (Lond.), 339: 626-629, 1989.
14. Moria, A. O. Draetta, G. Beach, D. and Wang, J. Y. J. Reversible tyrosine phosphorylation of cdc2: dephosphorylation accompanies activation during entry into mitosis. Cell, 58: 193-203, 1989.
15. Gould, K. and Nurse, P. Tyrosine phosphorylation of fission yeast cdc2+ protein kinase regulates entry into mitosis. Nature (Lond.), 342: 39-45, 1989.
16. Okura, A. Arakawa, H. Oka, H. Yoshinari, T. and Monden, Y Effect of genistein on topoisomerase activity and on the growth of (val 12) Ha-ras-transformed NIH 3T3 cells. Biochem. Biophys. Res. Commun. 157: 183-189, 1988.
17. Constantinou, A. Kiguchi, K. and Huberman, E. Induction of differentiation and DNA strand breakage in human HL-60 and K-562 leukemia cells by genistein. Cancer Res. 50: 2618-2624, 1990.
18. Kiguchi, K. Constantinou, A. I. and Huberman, E. Genistein-induced cell differentiation and protein-linked DNA strand breakage in human melanoma cells. Cancer Commun. 2: 271-278, 1990.
19. Chen, G. L. Yang, L. Rowe, T. C. Halligan, B. D. Tewey, K. M. and Liu. L. F. Nonintercalative antitumor drugs interfere with the breakage-reunion reaction of mammalian DNA topoisomerase II. J. Biol. Chem. 259: 13560-13566, 1984.
20. Yamashita, Y. Kawada, S. and Nakano, H. Induction of mammalian topoisomerase II dependent DNA cleavage by intercalative flavonoids, genistein and orabol. Biochem. Pharmacol. 39: 737-744, 1990.
21. Clarkson, J. M. and Humphrey, R. M. The effect of Adriamycin on cell cycle progression and DNA replication in Chinese hamster ovary cells. Cancer Res. 37: 200-205, 1977.
22. Kimler, B. F. Schneiderman, M. H. and Leeper, D. B. Induction of concentration-dependent blockage in the G2 phase of the cell cycle by cancer chemotherapeutic agents. Cancer Res. 38: 809-814, 1978.
23. Tagawa, Y Relationship between G2 accumulation and RNA content of PC 1 cells in unbalanced growth induced by antitumor agents. J. Jpn. Soc. Cancer Ther. 22: 590-602, 1987.
24. Barlogie, B. and Drewinko, B. Cell cycle stage-dependent induction of G2 phase arrest by different antitumor agents. Eur. J. Cancer, 14: 741-745, 1978.
25. Misra, N. C. and Roberts, D. Inhibition by 4’-demethyl-epipodophyllotoxin 9-(4,6-O-2-thenylidene-ß-D-glucopyranoside) of human lymphoblast cultures in G2 phase of the cell cycle. Cancer Res. 35: 99-105, 1975.
26. Hotz, M. A. Tráganos, F. and Darzynkiewicz, Z. Changes in nuclear chromatin related to apoptosis or necrosis induced by DNA topoisomerase II inhibitor fostriecin in MOLT-4 and HL-60 cells are revealed by altered DNA sensivity to denaturation. Exp. Cell Res. 201: 184-191, 1992.
27. Hosokawa, N. Hirayoshi, K. Nakai, A. Hosokawa, Y. Marui, N. Yoshida, M. Sakai, T. Nishino, H. Aoike, A. Kawai, K. and Nagata, K. Flavonoids inhibit the expression of heat shock proteins. Cell Struct. Funct. 15: 393-401, 1990.
28. Ohno, K. Sakai, T. Fukushima, M. Narumiya, S. and Fujiwara, M. Site and mechanism of growth inhibition by prostaglandins. IV. Effect of cyclopentenone prostaglandins on cell cycle progression of G|-enriched HeLa S3 cells. J. Pharmacol. Exp. Then, 245: 294-298, 1988.
29. Ohno, K. Fukushima, M. Fujiwara, M. and Narumiya, S. Induction of 68,000-dalton heat shock proteins by cyclopentenone prostaglandins. J. Biol. Chem. 263: 19764-19770, 1988.
30. Marui, N. Nishino, H. Sakai, T. Aoike, A. Kawai, K. and Fukushima, M. A'2-Prostaglandin J2 mimics heat shock in inducing cell cycle arrest at Gi phase. Biochem. Biophys. Res. Commun. 779: 1662-1669, 1991.
31. Iida, H. and Yahara, I. Durable synthesis of high molecular weight heat shock proteins in G0 cells of yeast and other eukaryotes. J. Cell Biol. 99: 199-207, 1984.
32. Nevins, J. R. Induction of the synthesis of a 70,000 dalton mammalian heat shock protein by the adenovirus El A gene product. Cell, 29: 913-919, 1982.
33. Kao, H.-T. Cappasso, O. Heintz, N. and Nevins, J. R. Cell cycle control of human HSP70 gene: implications for the role of a cellular EIA-like function. Mol. Cell. Biol. 5: 628-633, 1985.
34. van Dongen, G. and van Wijk, R. Evidence for a role of heat-shock proteins in proliferation after heat treatment of synchronized mouse neuroblastoma cells. Radiat. Res. 113: 252-267, 1988.